Abstract |
Prostate cancer is the most commonly diagnosed malignancy in men and shows a predilection for metastasis to distant organs. Bradykinin (BK) is an inflammatory mediator and has recently been shown to mediate tumor growth and metastasis. The adhesion molecule intercellular adhesion molecule-1 (ICAM-1) plays a critical role during tumor metastasis. The aim of this study was to examine whether BK promotes prostate cancer cell migration via ICAM-1 expression. The motility of cancer cells was increased following BK treatment. Stimulation of prostate cancer cells with BK induced mRNA and protein expression of ICAM-1. Transfection of cells with ICAM-1 small interfering RNA reduced BK-increased cell migration. Pretreatment of prostate cancer cells with B2 receptor, phosphatidylinositol 3-kinase (PI3K), Akt, and activator protein 1 (AP-1) inhibitors or mutants abolished BK-promoted migration and ICAM-1 expression. In addition, treatment with a B2 receptor, PI3K, or Akt inhibitor also reduced BK-mediated AP-1 activation. Our results indicate that BK enhances the migration of prostate cancer cells by increasing ICAM-1 expression through a signal transduction pathway that involves the B2 receptor, PI3K, Akt, and AP-1. Thus, BK represents a promising new target for treating prostate cancer metastasis.
|
Authors | Hsin-Shan Yu, Tien-Huang Lin, Chih-Hsin Tang |
Journal | International journal of molecular sciences
(Int J Mol Sci)
Vol. 14
Issue 7
Pg. 13329-45
(Jun 26 2013)
ISSN: 1422-0067 [Print] Switzerland |
PMID | 23803661
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- ICAM1 protein, human
- Neoplasm Proteins
- Vasodilator Agents
- Intercellular Adhesion Molecule-1
- Bradykinin
|
Topics |
- Bradykinin
(pharmacology)
- Cell Line, Tumor
- Gene Expression Regulation, Neoplastic
(drug effects, genetics)
- Humans
- Intercellular Adhesion Molecule-1
(biosynthesis, genetics)
- Male
- Neoplasm Proteins
(genetics, metabolism)
- Prostatic Neoplasms
(genetics, metabolism, pathology)
- Signal Transduction
(drug effects, genetics)
- Up-Regulation
(drug effects, genetics)
- Vasodilator Agents
(pharmacology)
|